Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial(†)(†)This trial is posted on clinicaltrials.gov (NCT00267670). This research was supported by investigator initiated funds

Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial(†)(†)This trial is posted on clinicaltrials.gov (NCT00267670). This research was supported by investigator initiated funds

Introduction. The burden of non-alcoholic steatohepatitis (NASH) is growing and current pharmacologic treatments are limited by side effects and inconsistent efficacy. Pilot studies suggest that pentoxifylline (PTX) can reduce liver injury in patients with NASH.Objective. We sought to determine the...

Full description

Bibliographic Details
Main Authors: Lisa B. Van Wagner, Sean W.P. Koppe, Elizabeth M. Brunt, Jeanne Gottstein, Konstantina Gardikiotes, Richard M. Green, Mary E. Rinella, M.D.
Format: Article
Language:English
Published: Elsevier 2011-07-01
Series:Annals of Hepatology
Subjects:
Non-alcoholic fatty liver disease
Obesity
Cirrhosis
TNF alpha
Unfolded protein response
Online Access:http://www.sciencedirect.com/science/article/pii/S166526811931539X

Internet

http://www.sciencedirect.com/science/article/pii/S166526811931539X

Similar Items